Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Palantir Technologies Inc (PLTR) Price & Performance

Ascendis Pharma A/STrade
Palantir Technologies IncTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Palantir Technologies Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Palantir Technologies Inc trades at $171.69 (market cap $420.39B). The key difference: Palantir Technologies Inc is far larger — about 25.2× Ascendis Pharma A/S's market cap. Which is the better fit depends on your goals.

ASNDPLTR
Market Cap
$16.67B$420.39B
Sector
HealthTechnology
52-Week High
$277.18$207.18
52-Week Low
$189.74$107.27
Enterprise Value
$17.04B$411.19B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Palantir Technologies Inc

Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.

Read more on PLTR